Duran, I., Giannatempo, P., Galsky, M. D., Boni, V., Necchi, A., Italiano, A., McKean, M., Verlingue, L., DeMars, L., Brown, G., Xu, C., Torras, O. R. (2026). Zelenectide pevedotin (BT8009) plus pembrolizumab in 1L cisplatin-ineligible locally advanced/metastatic urothelial carcinoma: Update on Duravelo-1 B7.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4564